Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001013156 | SCV001173704 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-10-19 | criteria provided, single submitter | clinical testing | The p.M60L variant (also known as c.178A>C), located in coding exon 2 of the APC gene, results from an A to C substitution at nucleotide position 178. The methionine at codon 60 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |